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Abstract
Background: Dengue viral infection is a global health threat without vaccine or specific treatment. The clinical outcome
varies from asymptomatic, mild dengue fever (DF) to severe dengue hemorrhagic fever (DHF). While adaptive immune
responses were found to be detrimental in the dengue pathogenesis, the roles of earlier innate events remain largely
uninvestigated. Invariant natural killer T (iNKT) cells represent innate-like T cells that could dictate subsequent adaptive
response but their role in human dengue virus infection is not known. We hypothesized that iNKT cells play a role in human
dengue infection.
Methods: Blood samples from a well-characterized cohort of children with DF, DHF, in comparison to non-dengue febrile
illness (OFI) and healthy controls at various time points were studied. iNKT cells activation were analyzed by the expression
of CD69 by flow cytometry. Their cytokine production was then analyzed after a-GalCer stimulation. Further, the CD1d
expression on monocytes, and CD69 expression on conventional T cells were measured.
Results: iNKT cells were activated during acute dengue infection. The level of iNKT cell activation associates with the disease
severity. Furthermore, these iNKT cells had altered functional response to subsequent ex vivo stimulation with a-GalCer.
Moreover, during acute dengue infection, monocytic CD1d expression was also upregulated and conventional T cells also
became activated.
Conclusion: iNKT cells might play an early and critical role in the pathogenesis of severe dengue viral infection in human.
Targeting iNKT cells and CD1d serve as a potential therapeutic strategy for severe dengue infection in the future.
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Introduction
Public health threat of dengue viral infection is expanding
globally and most prominent in tropical and subtropical countries.
It is the most significant mosquito- borne viral illness affecting
mankind. An estimated 2.5 billion people live in the area at risk
resulting in 50 to 390 million dengue infections per year [1–3].
Dengue infection causes significant morbidity, mortality and leads
to hospitalization that consume vast amount of health care
spending mostly in endemic areas where resource is scarce [1–3].
Currently, there is still no vaccine nor specific treatment, in part
due to our incomplete understanding of the disease pathogenesis.
Dengue virus (DV) is a single stranded RNA virus in the
Flaviviridae family. Four serotypes of dengue virus are circulat-
ing and cause human illness. The transmission from human to
human requires Aedes mosquito vectors [4]. Once infected with
DV, the clinical manifestation varies widely from asymptom-
atic infection, undifferentiated febrile illness to a more typical
dengue fever (DF) characterized by fever associated with severe
headache, myalgia, and bone pain, which are mild and self
limited. A small percentage of patients develop a more severe,
life threatening dengue hemorrhagic fever (DHF), which could
result in dengue shock syndrome (DSS) [1]. The hallmarks of
DHF/DSS are plasma leakage and hemorrhage that could lead
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to shock and death which invariably occur within 1–2 days
after fever subsided [1,5].
Both viral and host factors were shown to contribute to the
severity of dengue infection [1,6]. While protective immune
response is required for viral clearance, the detrimental immune
reaction was suggested to be the major cause of severe DHF/DSS
[6]. Most previous investigations focused on the detrimental effects
of cross-reactive adaptive immune responses known as antibody
dependent enhancement [7–9] and T cell antigenic sin [10].
However, the study on innate and innate-like immune response in
dengue infection that could initiate or even dictate the type of
subsequence adaptive immune response is still very limited.
Invariant natural killer T (iNKT) cells represent a unique
population of T cells with innate-like function. iNKT cells express
invariant T cell receptor (iTCR) recognizing lipid antigens on
CD1d, a non-polymorphic MHC class I –like molecule [11]. a-
Galactosylceramide (a-GalCer) is a potent and specific iNKT cell
antigen widely used for iNKT cell activation and identification
[11]. A number of exogenous lipid antigens from microbes [12–
15] and endogenous lipid antigens [16–19] were also shown to
activate iNKT cells. Upon activation, iNKT cells can rapidly
secrete a variety of preformed cytokines such as IFN-a, IL-4, IL-
17A, IL-10 and crosstalk with conventional T cells, B cells, NK
cells, macrophages and dendritic cells [11]. iNKT cells were
shown to play a role in many disease processes including cancer,
autoimmunity, asthma, and infections [11,20,21]. Their roles in
infections were demonstrated for a variety of microorganisms
including viruses [13–15,22–25].
The critical roles of iNKT cells were demonstrated in several
virus infections [24,25] such as herpes simplex virus type 1 and 2
[26–28], respiratory syncytial virus [29], influenza A virus [30–
32], hepatitis B virus [33], cytomegalovirus [34,35], hepatitis C
virus [36], and HIV-1 [37]. Moreover, patients with primary
immune deficiency resulting in iNKT cell defect are more
susceptible to severe varicella-zoster virus [38] and EBV infections
[39]. Because of these evidence, iNKT cells activation by a-
GalCer have been tested as vaccine adjuvant with promising
results in animal models of hepatitis B virus [40], influenza A virus
[41] and HIV infections [42,43].
The potential role of iNKT cells in pathogenesis of DV infection
has never been investigated in human. Two previous reports
showed increased number and recruitment of T cells bearing NK
cell markers to skin infected with DV in mouse [44] and marmoset
models [45]. However, these reports did not use standard methods
to identify iNKT cells, so it is unclear if these cells are truly iNKT
cells. The only study of iNKT cells in DV infection was done in
experimental murine model [46] and suggested a detrimental role
of iNKT cells in severe form of DV infection. However, DV does
not naturally infect mice and the use of mouse model to represent
DV infection pathogenesis in human remains controversial [47–
49]. Therefore, the study of iNKT cells in human patients is
needed.
Here, we investigated the potential role of iNKT cells in DV
infection in human by examining well-defined clinical samples
from a cohort of DV infected children of varying disease severity
and at different time points, in comparison to controls. We found
that iNKT cells were activated in acute DV infection, and
suggesting the involvement of iNKT cells in human severe DV
infection. A better understanding of the role of iNKT cells in
human DV infection will lead to a better understanding of the
intricate control of complex immune responses and immuno-
pathogenesis in dengue infection. Altogether, the advancement in
our knowledge will enable the development of novel preventive
and therapeutic approaches in the future.
Methods
Ethics statement
Blood samples were collected from healthy controls and 1–15
year-old patients admitted to Khon Kaen and Songkhla hospitals,
Thailand, following written parental informed consent. This
project was approved by the ethical committees of Khon Kaen
hospital, Songkhla hospital and Mahidol University.
Clinical samples
Peripheral blood mononuclear cells (PBMC) were separated
from whole blood by Ficoll-Hypaque density gradient centrifuga-
tion and kept in liquid nitrogen for subsequent study. Acute
dengue infection was determined by dengue gene identification
using reverse transcription PCR (RT-PCR) and dengue virus-
specific IgM capture ELISA as previously described [50,51].
Dengue disease severity was classified according to the World
Health Organization criteria (1997) [5] into dengue fever (DF) and
dengue hemorrhagic fever (DHF). Other non-dengue febrile illness
(OFI) patients were defined as patients hospitalized with fever
without the presence of dengue infection by both RT-PCR and
dengue virus-specific IgM capture ELISA.
Blood samples from each patient were collected at different time
points during the course of infection. The date were called in
relation to the day fever subsided (day of defervescence, day 0) so
that ‘‘day -1’’ is one day before the day of defervescence and
‘‘week 2’’ and ‘‘month 6’’ are 2 weeks and 6 months after the day
of defervescence, respectively. Random PBMC samples from DF,
DHF and OFI were used for analysis in this study.
Samples from 11 DF, 19 DHF, 11 OFI patients and 10 healthy
controls were evaluated for percentage and phenotype of
peripheral blood iNKT cells. The demographic and clinical
characteristics, including age, gender, DV serotype, lowest white
blood cells count (WBC), highest hematocrit (Hct), lowest platelet
(Plt), highest serum aspartate transaminase (AST), alanine
transaminase (ALT) enzyme, and lowest albumin of each patient
with DF and DHF are shown in Table S1. A different set of
patient samples were used to study the function of iNKT cells by ex
Author Summary
Almost half of the world population is at risk of dengue
viral infection. The disease severity varies from mild to a
deadly form-which is caused mainly by host overt immune
reaction. Earlier studies focused on the disease-causing
roles of adaptive immune cells - cells that are highly
specific but require time and signal from rapidly activating
immune cells to become active. Invariant Natural Killer T
(iNKT) cells are unique T cells that get activated rapidly and
can control later adaptive response by secreting cytokines.
They can be activated by lipid loaded on CD1d, an antigen
presenting molecule. However, their role in human
dengue infection was not known. Here, we studied iNKT
cells from dengue infected children and found that they
were activated. Importantly, the more severe the disease,
the higher level of iNKT cells activation. Their cytokine
patterns also differ from those of healthy donors.
Moreover, together with iNKT cells activation, the level of
CD1d was higher and T cells became active. Therefore,
iNKT cells likely play a role in the pathogenesis of human
dengue infection. New drugs targeting iNKT cells might
help dampen the disease severity before the adaptive
immune cells become too active.
NKT Cells in Human Dengue Infection
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vivo stimulation due to limited number of PBMC available from
each patient. Fourteen DF, 12 DHF, 11 OFI patients and 10
healthy controls were used in these experiments. Table S2 shows
demographic and clinical characteristics of the DHF and DF
patients whose PBMC were used for functional analysis. All
patients studied had secondary DV infection.
iNKT cell and T cell phenotypic analysis
To analyze the number and phenotypes of iNKT cells and
conventional T cells, cryopreserved PBMCs were thawed and
rested in cold complete RPMI medium. Cell numbers and viability
were estimated by trypan blue exclusion assay. More than 90%
cell viability were observed in all samples. Cells were then washed,
Fc blocked and stained with the following fluorescence-conjugated
monoclonal antibodies; PEcy7-conjugated anti-human CD3
(BioLegend; CA), PE-conjugated PBS57-loaded CD1d tetramer
or PE-conjugated unloaded CD1d tetramer (NIH tetramer facility,
USA; PBS57 is an a-GalCer analog), FITC-conjugated anti-
human CD4 (BD Pharmingen), APCcy7-conjugated anti-human
CD8 (BioLegend; CA), and PerCP- conjugated anti-human CD69
(or isotype control) (BD Biosciences) according to the manufac-
turer’s protocol. Cells were then analyzed by flow cytometry.
Cell culture, ex vivo stimulation and intracellular cytokine
analysis
Cryopreserved PBMCs were thawed and cultured in the
presence or absence of a-GalCer 100 ng/ml (KRN7000, Funa-
koshi, Tokyo, Japan) for 12 hours with brefeldin A (10 mg/ml;
Sigma-Aldrich). Cells were then harvested and stained for the
following surface markers and intracellular cytokines after
permeabilization according to manufacturer’s protocol: PEcy7
conjugated anti-human CD3 antibody (BioLegend; CA), PE
conjugated PBS57-loaded CD1d tetramer (NIH, USA), PerCP
conjugated anti-human CD69 antibody (BD Biosciences), FITC-
conjugated anti-human IFN-c (BD Pharmingen), APC-conjugated
anti-human IL-4 (eBioscience) and Alexa700-conjugated anti-
human IL-17A (BD Pharmingen) or isotype controls. Cells were
then fixed with 1% formaldehyde in PBS and analyzed by flow
cytometry.
Monocyte CD1d expression
PBMC were stained with FITC-conjugated anti-human CD14
antibody (BD Pharmingen), and PE-conjugated anti-CD1d
antibody (BD Pharmingen) or isotype control (BD Pharmingen).
Cells were then fixed and acquired by flow cytometry. Monocytes
were gated based on their characteristic appearance on FSC/SSC
dotplot and upon CD14 expression. The level of CD1d expression
was expressed as the difference in mean fluorescence intensity
(DMFI) between CD1d staining and isotype control of each
sample as baseline.
Flow cytometry
Flow cytometry analysis was performed using BD FACS Canto
or BD LSRII flow cytometer via FACS Diva version 4.1.1
software. FlowJo version 8.7 (Tree star) was used for data analysis.
Statistical analysis
Data analysis was performed using GraphPad Prism 5.0
software and SPSS version 20. Mann-Whitney test was used for
comparison of unpaired data. Wilcoxon signed rank test was used
to compare paired data. Spearman’s rho correlation test was used
for correlation analysis of non-parametric data. P-value of ,0.05
was considered as statistically significant difference.
Results
Demographic and clinical data
The age and gender of patients with DF and DHF in this study
were not significantly different. The most common DV serotypes
in both groups were DV serotype 1 (DV1), followed by DV2,
DV3, and DV4, respectively. As expected, patients with DHF had
significantly lower platelet count, serum albumin and higher liver
transaminases when compared to those with DF (Table S1 and
S2).
The percentage of peripheral blood iNKT cells remain
unchanged during the course of DV infection
To examine whether the percentage of iNKT cells changes
during the course of DV infection, PBMC from DF and DHF
patients were evaluated at 3 different time points (day -1, day 0
and day 2 weeks) as previously described (Figure 1a). Lymphocytes
were pregated based on their characteristic appearance on forward
and side scattered dot plot. iNKT cells were then identified by the
expression of both CD3 and PBS57- loaded CD1d tetramer (as
compared to unloaded CD1d tetramer control) (Figure 1a, 2a).
The percentage of iNKT cells within total lymphocytes were not
significantly changed over the course of DV infection in both
patients with DF (Figure 1b, Figure S1a) and DHF (Figure 1c,
Figure S1b). When comparing iNKT cells from patients with
various severities during febrile phase and controls, the percentage
of iNKT cells were also not significantly different between groups
of patients (Figure 1d). Absolute number of iNKT cells also
showed similar results (Figure S1c-g).
iNKT cells were activated during acute DV infection and
the level of activation associated with dengue disease
severity
To investigate whether iNKT cells are activated in vivo during
human DV infection, peripheral blood iNKT cells from dengue-
infected individuals with various disease severities were evaluated
at different time points. Expression of CD69 in comparison to
isotype control was used as an activation marker of iNKT cells
(Figure 2a).
iNKT cells were activated during acute phase (day -1 and day 0)
of dengue infection in both DF and DHF patients (Figure 2b). The
percentage of CD69 positive iNKT cells was significantly higher
during febrile phase (day -1) (median 3.02%; interquartile range
2.18–20.33%) and defervescence phase (day 0) (7.42%; 3.91–
13.23%) compared to 2 weeks after fever subsided (0.50%; 0.13–
2.08%) in patients with DF (p,0.05 and p,0.005 respectively)
(Figure 2c). In patients with DHF, the percentage of CD69 positive
iNKT cells was also higher during febrile phase (day -1) (27.40%;
17.20–36.80%) and defervescence phase (10.00%; 5.26–22.70%)
when compared to 2 weeks after fever subsided (0.23%; 0.00–
0.57%) (p,0.0001 and p= 0.0001, respectively) (Figure2d).
Furthermore, when comparing iNKT cells from patients with
various severities during febrile phase (day -1), patients with DHF
have significantly higher percentage of activated iNKT cells
(27.40%; 17.20–36.80%) when compared to DF (3.02%; 2.18–
20.33%) (p = 0.0149) (Figure 2e), suggesting that the activation of
iNKT cells associated with disease severity. Moreover, iNKT cells
were more activated in dengue-infected patients (DF and DHF)
than in OFI (1.77%; 0.00–7.33%) and healthy controls (0.00%;
0.00–0.51%) (Figure 2e). iNKT cell activation in OFI is higher
than healthy controls (p,0.05), possibly due to the heterogeneous
non-dengue infectious etiology of OFI group, some of which could
also activate iNKT cells.
NKT Cells in Human Dengue Infection
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When cells from each patient were analyzed at 3 different time
points, the data clearly showed that the percentage of activated iNKT
cells were highest during febrile phase, continuously decreased over the
course of infection and barely present by 2 weeks after fever subsided in
both patients with DF (Figure 2f) and DHF (Figure 2g). No correlation
between iNKT cell activation and DV viral load was observed (data
not shown). Therefore, our results showed that iNKT cells were
activated during acute dengue infection and the level of activation
associated with dengue disease severity.
Peripheral blood iNKT cells from acute DV infected
patients had reduced a-GalCer mediated production of
IFN-c
To study function of the iNKT cells in DV infection, iNKT cells
production of various cytokines (IFN-c, IL-4 and IL-17) were
analyzed by intracellular cytokine staining of gated iNKT cells in
comparison to isotype controls. Without stimulation, a small
amount of IFN-c and IL-4 could be detected in iNKT cells from
some of the acute dengue-infected patients (Figure 3a–b, 3e–f).
Previous reports demonstrated that iNKT cells could become
anergic or hyporesponsive to a-GalCer stimulation if they were
previously activated in vivo [52,53]. To further examine the
functional properties of the activated iNKT cells from acute DV
infected patients, the PBMC were stimulated with a-GalCer ex vivo
and intracellular cytokines were evaluated. PBMC from DF and
DHF patients during acute dengue infection (day 0) were
compared to those 6 months after infection, when the immuno-
logical effects of acute DV infection were assumed to return to
baseline. The results were then compared with unstimulated
condition and with PBMC from OFI and healthy subjects
(Figure 3).
As expected, after a-GalCer stimulation, healthy iNKT cells
produced large amount of IFN-c (Figure 3c). In contrast, the
capacity to produce IFN-c of iNKT cells from acute DV infected
and OFI patients was reduced (Figure 3c, Figure S2a). At day 0,
after stimulation, the percentage of IFN-c+ iNKT cells of patients
with DF (16.35%; 14.40–24.93%) and DHF (11.95%; 6.77–
18.30%) were lower than those of healthy control (32.1%; 25.90–
40.70%) (p= 0.002 and p= 0.01, respectively) (Figure 3c). There-
fore, the functional change of iNKT cells is not limited to dengue
infection but also occur in other febrile illness, again, this could be
due to the heterogeneous infectious etiology of OFI. No significant
difference between DF and DHF was observed. The responsive-
ness to a-GalCer stimulation returned 6 months after fever
subsided to the level similar to those of healthy control (Figure 3d).
After a-GalCer stimulation, the percentage of IFN-c+ iNKT cells
from day 0 were significantly lower than those from 6 months after
fever subsided in both patients with DF (day 0: 16.35%; 14.40–
24.93% vs. month 6: 29.20%; 19.65–43.00%, p= 0.002)
(Figure 3a) and DHF groups (day 0:11.95%; 6.77–18.30% vs.
month 6: 25.65%; 15.35–37.23%, p= 0.01) (Figure 3b). No
statistical significant difference was observed when IL-4+ iNKT
cells were examined after a-GalCer stimulation (Figure 3e–h,
Figure S2b).
Interestingly, the iNKT cells cytokine patterns in DF and DHF
appears to be different. Acute DF patients have higher IFN-c/IL-4
ratio compared to DHF (Figure 3i), suggesting that Th1-like
response of iNKT cells in acute DV infection may associate with
less disease severity.
IL-17A was not detectable in iNKT cells in all conditions with
the current stimulation protocol (data not shown), perhaps because
the kinetics of IL-17 is different from IL-4 and IFN-c.
Figure 1. The frequency of peripheral blood iNKT cells during dengue infection with different disease severity. a) Representative dot
plots show the percentage of iNKT cells within lymphocytes in healthy, other febrile illness (OFI), dengue fever (DF), and dengue hemorrhagic fever
(DHF) at day -1, day 0 and day 2 weeks. b, c) Each dot represents percentage of iNKT cells of each patient in DF (b) and DHF (c) groups at 3 different
time points, the line represents median of each group. d) The percentage of iNKT cells during febrile phase (day -1) of healthy, OFI, DF and DHF.
Mann-Whitney test (b–d) was used for statistical comparison, p,0.05 was considered as statistically significant difference. No significant difference
was found.
doi:10.1371/journal.pntd.0002955.g001
NKT Cells in Human Dengue Infection
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To further examine the kinetics of functional response of iNKT
cells to a-GalCer, additional time points at day -1 and week 2 were
studied (Figure S3 and S4). The responses at these 2 additional
time points were not statistically significant different. However,
iNKT cells from DHF at 2 weeks appeared to produce more IFN-
c than at day -1 but due to the limited number of sample,
statistical test cannot be performed (Figure S4b). Altogether, the
IFN-c response to a-GalCer seems to reduce during acute DV
infection and recover by month 6 after acute DV infection but the
rate of recovery may differ between patients.
Taken together, these findings suggested that iNKT cells from
acute dengue infected patients were previously activated in vivo and
upon restimulation with a-GalCer ex vivo, they have reduced IFN-c
production. Importantly, skewing toward Th1-like cytokine
pattern of iNKT cells during acute DV infection may associate
with less clinical severity.
Upregulation of CD1d expression on monocytes during
acute DV infection
Our next question was how iNKT cells get activated during
acute DV infection. iNKT cells were known to be activated by
cognate recognition of iNKT cell receptor to antigen presented on
CD1d. In some circumstances, they can be activated indirectly by
cytokines or might require both cognate recognition and cytokine-
driven activation [54]. To first investigate if iNKT cells could be
activated through the CD1d-dependent pathway, we measured
CD1d expression on monocytes from the same patient samples
used to study iNKT cells. Monocytes were examined because they
Figure 2. iNKT cells were activated during acute phase of dengue infection. a) Representative dot plot and histogram demonstrate gating
strategy for iNKT cells and CD69 expression on iNKT cells. iNKT cells were gated, within lymphocytes population, on CD3+, PBS57-loaded CD1d
tetramer+ (in comparison with unloaded CD1d tetramer control). CD69+ iNKT cells were gated in comparison to isotype control. b) Flow cytometry
analysis of the expression of CD69 on iNKT cells in Healthy, OFI, DF, and DHF at day -1, day 0 and 2 weeks. Representative histograms show the
expression of CD69 (black line) in comparison to isotype control (gray shade). c, d) Each dot represents percentage of CD69 positive iNKT cells of each
patient in DF (c) and DHF (d) groups at 3 different time points, the line indicate median of each group. e) Dot plot summarized percentage of CD69
positive iNKT cells during febrile phase (day -1) of each group of patients in comparison to controls. f, g) Percentage of CD69 positive iNKT cells
during the course of dengue infection, each line connects data from each patient at various time points. Mann-Whitney test (c–e), and Wilcoxon
signed rank test (f–g) were used for statistical comparison, p,0.05 was considered as statistically significant difference (*p,0.05, **p,0.01, ***p,
0.001).
doi:10.1371/journal.pntd.0002955.g002
NKT Cells in Human Dengue Infection
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Figure 3. Cytokines production by iNKT cells from dengue infected patients with and without stimulation with a-GalCer. Each dot
represents percentage of interferon gamma (IFN-c)+ (a–b) and IL-4+ (e–f) iNKT cells from DF (a,e) and DHF (b,f) at day 0 and month 6, with (stimulated)
and without (unstimulated) a-GalCer stimulation. At day 0 (c, g, i) and 6 months (d, h, j), percentage of IFN-c+ iNKT cells (c,d), IL-4+ iNKT cells (g, h) and
IFN-c/IL-4 ratio (i, j) upon a-GalCer stimulation, comparing cells from healthy, OFI, DF and DHF groups. Mann-Whitney test, were used for statistical
comparison, p,0.05 was considered as statistically significant difference (*p,0.05, **p,0.01, ***p,0.001).
doi:10.1371/journal.pntd.0002955.g003
NKT Cells in Human Dengue Infection
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are abundant antigen presenting cells in peripheral blood, known
to be infected by dengue virus both in vivo and in vitro, and also
known to activate iNKT cells in other circumstances. Monocytes
were first gated (Figure 4a) and the level of CD1d expression on
monocytes at different time points was then analyzed in
comparison to isotype control in both DF and DHF groups
(Figure 4b). Interestingly, the expression of CD1d was highest on
monocytes during day -1 and day 0, in both DF (median DMFI
16058;13304–18998 (day -1) and 15682; 13820–20191 (day 0))
and DHF (17499; 14987–22505 (day -1) and 17991; 15896–21235
(day 0)) patients. The level of CD1d expression decreased
significantly by 2 weeks after fever subsided in both DF (10184;
7962–11852) (p = 0.002 (day -1 vs. 2 weeks), p = 0.01 (day 0 vs. 2
weeks)) and DHF (9645; 8999–12712) (p = 0.008 (day -1 vs. 2
weeks), p = 0.002 (day 0 vs. 2 weeks)) (Figure 4c) to the same level
as healthy control (10504; 9704–13541) (Figure 4d). The similar
trend is clearly observed when data from the same patients at 3
different time points were analyzed (Figure 4e). Monocytic CD1d
expression at 6 months was similar to those at 2 weeks (data not
shown). Furthermore, when comparing between patients with
different dengue disease severity, the level of monocyte CD1d
expression at day -1 was higher in DHF than in healthy control
(10504; 9704–13541) (p = 0.01), but not significantly higher than
that of DF (p = 0.27) (Figure 4d). Thus, CD1d expression on
monocytes was upregulated in acute DV infection. Moreover, the
level of CD1d expression on monocytes positively correlates,
although weakly, with the level of iNKT cell activation (r = 0.35,
p,0.05). The correlation is stronger when the DHF subgroup was
analyzed (r = 0.7, p = 0.002) (Figure S5). These results suggested
that CD1d was upregulated in monocytes during acute DV
infection. However, future experiments are needed to delineate if
iNKT cells were actually activated in a CD1d-dependent manner
in DV infection.
Cytotoxic T cells were activated in relation to iNKT cell
activation
In general, once iNKT cells get activated, they were known to
influence adaptive T cell immune response. To investigate if
iNKT cells activation were associated with the activation of
conventional T cells in DV infection, the percentage of CD8+ and
CD4+ T cells as well as their activation state were evaluated in the
PBMC samples that were used for iNKT cells studies. Lympho-
cytes were pregated based on their characteristic appearance on
forward and side scattered dot plot. CD8+ and CD4+ conventional
T cells were then identified by the expression of CD8 or CD4
together with CD3. CD69 in comparison with isotype control was
used as activation marker of both CD4+ and CD8+ T cells (Figure
S6a, c).
Similar to iNKT cell activation, conventional CD8+ T cells were
activated during acute phase of dengue infection in both DF and
DHF patients (Figure 5a,b). The percentage of CD69+CD8+
conventional T cells at day -1 (7.62%; 3.36–10.92) was higher than
2 weeks after fever subsided (0.56%; 0.24–1.48) in patients with
DF (p= 0.01) (Figure 5a). In patients with DHF, the percentage of
CD69+ CD8+ conventional T cells was higher at day -1 (10.35%;
7.99–13.08) and day 0 (2.40%; 0.52–8.71) when compared to 2
Figure 4. Upregulation of CD1d expression on monocytes during acute DV infection. a) Monocytes were gated on their typical FSC/SSC
appearance and on the presence of CD14. b) Representative histogram showed the level of CD1d expression on monocytes at different time points,
day -1 (black line), day 0 (gray line), 2 week (dotted line) in comparison to isotype control (shaded gray) in DF and DHF groups and in healthy control.
The level of CD1d expression was expressed as the difference in mean fluorescence intensity (dMFI) between CD1d staining and isotype control of
each sample. c) Each dot represents CD1d dMFI on monocytes of each patient in DF and DHF groups at 3 different time points, the line represents
median of each group. d) Monocytes CD1d dMFI during febrile phase (day -1) (left) and 2 weeks (right) of healthy, OFI, DF and DHF. e) Monocytes
CD1d dMFI during the course of dengue infection. Each line connects data from each patient at different time points. Mann- Whitney test (c–d), and
Wilcoxon signed rank test (e) were used for statistical comparison, p,0.05 was considered as statistically significant difference (*p,0.05, **p,0.01).
doi:10.1371/journal.pntd.0002955.g004
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weeks after fever subsided (0.30%; 0.14–0.57) (p,0.0001 and
p=0.0008 respectively) (Figure 5b). Furthermore, during febrile
phase, patients with DF (7.62%; 3.36–10.92) and DHF (10.35%;
7.99–13.08) have significantly higher percentage of activated CD8+
T cells when compared to OFI (0.76%; 0.15–1.38), and healthy
controls (0.32%; 0.026–0.565) (DF vs OFI, p= 0.01, DF vs healthy,
p= 0.005, DHF vs OFI, p,0.0001 and DHF vs healthy, p= 0.0001
respectively). At day -1, the percentage of activated CD8+ T cells of
DHF appeared to be higher than DF, but did not reach statistical
significance (Figure 5c). This is different from previous reports that
showed a higher CD8 activation in DHF compared to DF [55–57],
possibly due to the small sample size, high variability of the data and
different time point analyzed. When cells from each patient were
analyzed at 3 different time points, most of the data showed the
percentage of activated CD8+ conventional T cells were highest
during febrile phase, continuously decreased over the course of
infection and almost absent by 2 weeks after fever subsided in both
patients with DF (Figure 5d) and DHF (Figure 5e). The activation of
CD8+ conventional T cells correlates with iNKT cell activation
(r = 0.56, p,0.0100) especially in DHF patients (r = 0.69, p,
0.0100) (Figure S6b), suggesting that iNKT cell activation may
associate with the activation of CD8+ conventional T cells especially
in DHF patients.
At the analyzed time point, CD4+ conventional T cells were also
activated during acute DV infection but to a lesser extent than
CD8+ T cells and were more prominent in DHF patients
(Figure 5f–j). In DHF, but not DF patients, CD4+T cells showed
higher activation during day -1 (0.72%; 0.36–1.44) and day 0
(0.38%; 0.11–0.59) when compared to 2 weeks afterward (0.07%;
0.03–0.15) (p,0.0001, p = 0.013) (Figure 5g, j). During day -1, DF
and DHF patients showed increased CD4+ T cells activation when
compared to healthy controls or OFI (Figure 5h). No significant
difference was observed between DF and DHF (Figure 5h),
although it appears that only a few DF patients showed increased
CD4+ T cell activation (Figure 5h, i). The level of CD4+ T cell
activation also weakly correlates with the level of iNKT cells
activation (r = 0.41, p,0.01), but the correlation is more
prominent in DHF (r = 0.57, p,0.01) (Figure S6d).
Discussion
Our finding is the first to show that human iNKT cells are
activated during acute dengue viral infection and the level of
activation associates with disease severity. The activation subsided
by 2 weeks after fever subsided. Furthermore, the activated iNKT
cells from acute DV infected patients produced less IFN-c in
Figure 5. Activation of conventional T cells during acute phase of dengue viral infection. CD8+ and CD4+ conventional T cells were
identified by the expression of CD8 or CD4 together with CD3 within lymphocytes population. The expression of CD69 on CD8+ or CD4+ conventional
was gated in comparison to isotype control. Each dot represents percentage of CD69+CD8+ (a–e) and CD69+CD4+ (f–j) conventional T cells of each
patients in DF (a, f) and DHF (b, g) group at 3 different time points, the line indicate median of each group. e, h) Dot plot summarized percentage of
CD69+ CD8+ (c) and CD69+ CD4+ (h) conventional T cells during day -1 of each group of patients in comparison to OFI and healthy controls.
Percentage of CD69+ CD8+ (d, e) and CD69+ CD4+ (i, j) conventional T cells during the course of dengue infection in DF (d, i) and DHF (e, j), each line
connects data from each patient at various time points. Mann-Whitney test (a–c, f–h), and Wilcoxon signed rank test (d–e, i–j) were used for statistical
comparison, *p,0.05, **p,0.01, ***p,0.001, p,0.05 was considered as statistically significant difference.
doi:10.1371/journal.pntd.0002955.g005
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response to subsequent a-GalCer stimulation ex vivo. During acute
DV infection, monocytes also upregulated CD1d expression and
conventional T cells were activated.
The association between the level of iNKT cell activation and
the severity of dengue infection in our human data suggests that
activated iNKT cells might contribute to the pathogenesis of
severe dengue infection. Further investigations are needed to
dissect detailed mechanistic involvement of activated iNKT cells in
severe dengue disease pathogenesis. It is possible that the activated
iNKT cells contribute to immunopathology in severe dengue
infection. Alternatively, activated iNKT cells could play a
regulatory role that might impede viral clearance resulting in the
severe disease. We favor the former hypothesis because our data
showed that the activation state of iNKT cells correlates with the
activation of conventional T cells known to play pathogenic role in
severe disease. In addition, previously published murine data
showed that iNKT cell deficient mice suffer less sign of plasma
leakage, a cardinal feature of DHF, and survived more than wild
type mice [46]. The plasma leakage and death were restored after
iNKT cells reconstitution [46]. These data together suggested that
iNKT cells might play a detrimental role in dengue virus infection
in mice and human.
Despite the finding of iNKT cell activation during acute dengue
infection, the change in number of iNKT cell in peripheral blood
was not observed during the course of infection. It is possible that
iNKT cell migrate from intravascular space to affected tissues
unexamined as suggested in some animal models [44]. Moreover,
some activated iNKT cells might downregulate their iTCR
rendering them undetectable by a-GalCer-loaded CD1d tetramer
staining [11].
When the functional capacity of iNKT cells from dengue-
infected patients was evaluated, these iNKT cells had reduced a-
GalCer mediated IFN-c production. Six months after fever
subsided, their IFN-c production capacity upon a-GalCer
stimulation resumed to the level similarly found in healthy control,
possibly from a new pool of iNKT cells. The rate of functional
recovery varies among patients as seen at 2 weeks after fever
subsided. This finding was not surprising as several previous
reports consistently showed an unresponsiveness of previously
activated iNKT cells to subsequent stimulation, a phenomenon
known as iNKT cell anergy [52,53,58]. Similar to our finding,
they observed reduction in IFN-c, but not IL-4, in response to
subsequent a-GalCer stimulation. Therefore, this finding support
that iNKT cells were activated during acute dengue virus infection
in vivo, rendering them less responsive to subsequent stimulation ex
vivo, while their functional capacity returned 6 months after the
fever subsided. Interestingly, iNKT cells from acute DF patients
has higher IFN-c/IL-4 ratio after ex-vivo a-GalCer stimulation
than those from acute DHF patients. This finding suggests that
cytokines pattern produced by iNKT cells could possibly influence
DV disease severity. It would be interesting to know the pattern of
cytokine production of iNKT cells in vivo during the actual dengue
infection. Unfortunately, we could detect only small amount of
intracellular cytokines on iNKT cells from patients without any
stimulation, which may be because they secreted most cytokines in
vivo or because our detection sensitivity is limited by using
cryopreserved PBMC. Further study is warranted to delineate the
function of iNKT cells during acute DV infection in vivo.
In parallel with iNKT cell activation during acute DV infection,
monocytic CD1d surface expression was upregulated. This finding
suggests the possible involvement of CD1d on iNKT cell
activation through cognate recognition pathway although further
experiments are needed to demonstrate how iNKT cells are
activated in acute dengue infection. Moreover, CD1d expression
on other antigen presenting cells beside monocytes such as
dendritic cells may be interesting to examine. Some viruses such as
coxakievirus B3 [59] and hepatitis C virus [60] are known to
upregulate CD1d expression and activate iNKT cells while others
evade iNKT cell recognition by downregulating CD1d, such as
Kaposi sarcoma-associated herpes virus [61], herpes simplex virus
type 1 [62], HIV type 1 [63,64] and human papilloma virus [65].
Since viruses do not contain viral lipid antigens, it is postulated
that viral infection may alter endogenous lipid presented on CD1d
and activate iNKT cells with or without help from cytokines
[66,67]. Since viruses do not contain viral lipid antigens, altered
endogenous lipid might be presented on CD1d [29]. Indeed,
recent data suggested alteration of lipid metabolism in DV infected
cells but their importance in iNKT cell activation is not yet known
[68]. Other possible mechanism to activate iNKT cells, especially
cytokine mediated activation, was not evaluated and warrants
further study. Cytokines of special interest include, but not limited
to, IL-12, IL-18, IL-1b and IL-23. Further investigation is needed
to delineate the detail of how dengue virus upregulates CD1d and
how exactly iNKT cell activation was achieved in human DV
infection.
Once iNKT cells are activated, they are known to influence
other immune cells both in innate response such as NK cells,
dendritic cells and in adaptive T cell and B cell responses [11,20].
T cells are very important arm of immune defense against viral
infection, but T cell overactivation can lead to immunopathology
in dengue infection [69,70]. Our results showed the association
between iNKT cells activation, T cell activation and disease
severity. Consistently, in murine model, mice without iNKT cells
had less T cell response and less dengue disease severity [46].
However, whether iNKT cell activation leads to T cells activation
in human DV infection is not known and require further study.
The possible crosstalk of iNKT cells with other immune cells such
as B cells and NK cells in DV infection are also subjects of interest
for future study.
Secondary dengue infection is associated with higher disease
severity. It would be interesting to compare iNKT cell response in
primary and secondary dengue infection. However, because
Thailand is a hyper endemic area, most of our cohort samples
are secondary DV infection. Therefore, primary infection was not
evaluated in this current study.
In summary, we provide the first evidence that iNKT cells
may play a role in human DV infection, one of the most
important and expanding global health problems. As neither
vaccine nor specific treatment are available for DV infection,
and detrimental immune response might cause severe disease
rather than protect the host, a better understanding of how
immune response are regulated is crucial. We showed here the
possible involvement of iNKT cells in human DV infection.
Therefore, CD1d and iNKT cells may serve as attractive
targets for designing novel strategy to help alleviate suffering
from DV infection in the future.
Supporting Information
Figure S1 The percentage and absolute number of
peripheral blood iNKT cells during the course of dengue
infection. a, b) The percentage of iNKT cells during the course
of dengue infection in each patient with DF (a) and DHF (b). Each
line connects data from each patient at different time points. c, d)
Each dot represents the absolute numbers of iNKT cells
(x103 cells/ml) of each patient in DF (c) and DHF (d) groups at
3 different time points, each line represents median of each group.
e) The absolute number of iNKT cells during day -1 of OFI, DF
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and DHF. f, g) The absolute iNKT cells during the course of
dengue infection in DF (f) and DHF (g) groups. Each line
connects data from each patient at different time points. Mann-
Whitney test (c–e), and Wilcoxon signed rank test (a–b, f–g) were
used for statistical comparison, *p,0.0500, **p,0.0100, ***p,
0.0010.
(TIF)
Figure S2 Contour plot of cytokines production by iNKT
cells at day 0 and month 6. Pregated on iNKT cells,
representative contour plots show the production of IFN-c (a)
or IL-4 (b) within iNKT cells in comparison to isotype control
in healthy, OFI, DF and DHF groups, at day 0 or 6 months,
with (stimulated) and without (unstimulated) a-GalCer
stimulation.
(TIF)
Figure S3 Contour plot of cytokines production by iNKT
cells at day -1 and week 2. Pregated on iNKT cells,
representative contour plots show the production of IFN-c (a)
or IL-4 (b) within iNKT cells in comparison to isotype control
in healthy, OFI, DF and DHF groups, at day 0 or 6
months, with (stimulated) and without (unstimulated) a-GalCer
stimulation.
(TIF)
Figure S4 Cytokines production by iNKT cells from
dengue infected patients at day -1 and week2 with and
without stimulation with a-GalCer. Each dot represents
percentage of interferon gamma (IFN-c)+ (a-b) and IL-4+ (e–f)
iNKT cells from DF (a,e) and DHF (b,f) at day -1 and week 2, with
(stimulated) and without (unstimulated) a-GalCer stimulation. At
day -1 (c, g, i) and week 2 (d, h, j), percentage of IFN-c+ iNKT cells
(c,d), IL-4+ iNKT cells (g, h) and IFN-c/IL-4 ratio (i, j) upon a-
GalCer stimulation, comparing cells from healthy, OFI, DF and
DHF groups. Mann-Whitney test, were used for statistical
comparison, p,0.05 was considered as statistically significant
difference (*p,0.05).
(TIF)
Figure S5 CD1d expression on monocytes correlates
with the activation of iNKT cells. Spearman rho’s correlation
analysis of %CD69+ iNKT cells and difference in mean
fluorescence intensity (dMFI) of CD1d on monocytes in all
patients combined (a) or in only patients with dengue hemorrhagic
fever (DHF) (b).
(TIF)
Figure S6 Activation of conventional T cells correlates
with the activation of iNKT cells. a, c) Representative
histogram showed expression of CD69 on CD8+ (a) and CD4+ (c)
conventional T cells in healthy, OFI, DF, and DHF at day -1, day
0 and 2 weeks. Representative histograms show the expression of
CD69 (black line) in comparison to isotype control (gray shade). b,
d) Spearman rho’s correlation analysis of %CD69+ iNKT cells and
of %CD69+CD8+T cells in all patients combined (a) or in only
patients with dengue hemorrhagic fever (DHF) (b). Spearman
rho’s correlation analysis of %CD69+iNKT cells and of
%CD69+CD8+T cells (b) and %CD69+iNKT cells and of
%CD69+CD4+T cells (d) in all patients combined (ALL) or in
only patients with dengue hemorrhagic fever (DHF) (d).
(TIF)
Table S1 Characteristics of the patients (samples used
for phenotypic analysis of peripheral blood iNKT cells).
(PDF)
Table S2 Characteristics of the patients (samples were
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